Plant Comparison
Pot marigold vs Milk Thistle
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Pot marigold and Milk Thistle: both belong to the Asteraceae family; they share 4 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Pot marigold | Milk Thistle | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 5/10 | Comparable evidence |
| Cancer (anticancer research) | 7/10 | 7/10 | Comparable evidence |
| Inflammation (general) | 5/10 | 5/10 | Comparable evidence |
| Skin irritation | 5/10 | 5/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Principal wound-healing and anti-inflammatory constituents of the flower.
Antioxidant flavonoids and carotenoids give the flower its orange-yellow colour and contribute to its antioxidant activity.
Minor aromatic and resinous constituents of the flower head.
Pharmacological Actions
Calendula officinalis extracts show cytotoxic antitumor, pro-apoptotic and antimetastatic activity across many cancer cell lines and in animal models (preclinical).
Improves glycemic control in type 2 diabetes - lowers fasting blood glucose and HbA1c
Anti-inflammatory and antioxidant; Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic)
Digestive support / mild dyspepsia (traditional)
Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic); May improve liver enzymes and hepatic fat in non-alcoholic fatty liver disease (NAFLD); Supports liver recovery and 'detox' (traditional framing of the hepatoprotective action)
Traditional & Indicated Uses
inferred from anti-inflammatory action
A Calendula officinalis (LACE) aqueous extract inhibits proliferation (70-100%) of leukemia, melanoma, breast, prostate, lung and colon cancer cell lines via G0/G1 arrest and caspase-3 apoptosis and inhibits melanoma growth in nude mice; a systematic review documents its cytotoxic and antimetastatic antitumour activity (preclinical).
inferred from antifungal action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Improves glycemic control in type 2 diabetes - lowers fasting blood glucose and HbA1c
inferred from anticancer action
Supports liver recovery and 'detox' (traditional framing of the hepatoprotective action)
Digestive support / mild dyspepsia (traditional)
inferred from anti-inflammatory action
Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic); May improve liver enzymes and hepatic fat in non-alcoholic fatty liver disease (NAFLD)
inferred from antidiabetic action
Safety, Cautions & Contraindications
Generally very safe for topical use. May cause contact dermatitis in rare cases (Asteraceae family allergy). Internal use is safe in normal doses. Avoid during pregnancy at therapeutic doses (uterine stimulant potential). Generally safe during breastfeeding for topical use.
Duke (2002) rates calendula (Calendula officinalis) and notes anti-inflammatory, wound-healing (vulnerary), antifungal, and antispasmodic activities at experimental levels. Commission E (KOM) approves calendula flower for wound healing and anti-inflammatory uses, both topically and as a gargle. The plant contains flavonoids, triterpene saponins (oleanolic acid glycosides), and essential oils. Dose: 1–2 g dried flower as tea (for mouth rinse/gargle); or as cream/ointment containing 2–5% calendula extract for topical use. Duke notes that calendula is generally very well-tolerated, though Asteraceae sensitivity can occasionally cause allergic reactions (Duke, 2002).
Very well tolerated, even at high doses; the main effects are mild gastrointestinal upset (nausea, loose stools). As a member of the daisy family (Asteraceae), it can cause allergic reactions in sensitive people.
Has a low potential for drug interactions (little effect on liver CYP enzymes), but use caution with medicines that have a narrow therapeutic window. Human pregnancy data are limited, so use cautiously.
External Ids
Botanical Description
Aromatic annual or short-lived perennial herb with soft, hairy, oblong leaves and branching, slightly sticky stems. The flower heads are bright orange to yellow, daisy-like, with numerous narrow ray florets surrounding a darker central disc, opening in sunlight and closing at dusk.[1]
Robust biennial (occasionally annual) thistle (Asteraceae), 30-150 cm tall. Leaves are glossy dark green with distinctive white marbled veining (the 'milk' of legend), spiny-margined and deeply lobed. Large, solitary, purple-pink thistle-type flower heads are surrounded by spiny bracts, followed by shiny, mottled brown-black seeds - the part used.[12]
Habitat
Widely cultivated as a garden and medicinal plant; believed native to southern Europe and the Mediterranean, now naturalised in gardens and waste ground worldwide.[1]
Native to the Mediterranean region, now naturalised worldwide on disturbed, sunny ground - roadsides, waste places and dry pastures - and widely cultivated commercially for its seed.[12]
Harvesting
The flower heads (or just the ray-floret petals) are picked by hand as they open, through the flowering season, and dried quickly in a warm, shaded, airy place to preserve colour and resin content.[1]
Seed heads are harvested once fully dry (late summer), and the seeds (fruit) are threshed out.[12]
Traditional Uses
Calendula flower is one of the most widely used topical wound-healing and skin-soothing herbs in Western herbal medicine, applied to cuts, grazes, minor burns and skin inflammation, and used internally as a gentle anti-inflammatory and antimicrobial remedy and as a gargle for mouth and throat irritation.[1]
Milk thistle has a very long European folk-medicine tradition, documented since antiquity, as a liver tonic, and its seed extract, standardised to the flavonolignan complex silymarin, is one of the most extensively studied herbal hepatoprotectants. Modern research supports antioxidant, anti-inflammatory and liver-protective activity, with growing interest in metabolic/blood-sugar effects.[12, 13]
Preparations
Dried petals infused in a carrier oil, used as a soothing base for topical creams and balms for skin healing.
Standardised flower extract formulated into a cream or ointment for topical wound and skin care; the best-studied modern form.
Dried flower infused in hot water, 1-2 g in 150 ml, used still warm as a mouth rinse or gargle 2-4 times daily. The EU herbal monograph's posology for this preparation is OROMUCOSAL only - it does not support taking the infusion internally. Educational reference only, not a prescription.
Dosage
The EU herbal monograph gives semi-solid preparations containing the equivalent of 2-10% herbal substance, applied as a thin layer to the affected area 2 to 4 times daily. Educational reference only, not a prescription.
The EU herbal monograph gives 1-2 g of the flower in 150 mL water as an infusion, used still warm for rinsing and gargling 2 to 4 times daily, or to prepare impregnated dressings for the skin. This is an oromucosal and cutaneous preparation, not an oral tea. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
References & Sources
- Givol, O., Kornhaber, R., Visentin, D., Cleary, M. et al (2019) 'A systematic review of Calendula officinalis extract for wound healing', Wound Repair and Regeneration, 27(5), pp. 548-561. doi:10.1111/wrr.12737 Meta-analysis / review
https://doi.org/10.1111/wrr.12737 - Shahane, K., Kshirsagar, M., Tambe, S., Jain, D. et al (2023) 'An Updated Review on the Multifaceted Therapeutic Potential of Calendula officinalis L', Pharmaceuticals (Basel), 16(4), pp. 611. doi:10.3390/ph16040611 Traditional / reference
https://doi.org/10.3390/ph16040611 - Saffari, E., Mohammad-Alizadeh-Charandabi, S., Adibpour, M., Mirghafourvand, M. et al (2016) 'Comparing the effects of Calendula officinalis and clotrimazole on vaginal Candidiasis: A randomized controlled trial', Women & Health, 57(10), pp. 1145-1160. doi:10.1080/03630242.2016.1263272 Randomized trial
https://doi.org/10.1080/03630242.2016.1263272 - Cruceriu, D., Balacescu, O. and Rakosy, E (2018) 'Calendula officinalis: potential roles in cancer treatment and palliative care', Integrative Cancer Therapies, 17(4), pp. 1068-1078. doi:10.1177/1534735418803766 Meta-analysis / review
https://doi.org/10.1177/1534735418803766 - Rezai, S., Rahzani, K., Hekmatpou, D. and Rostami, A (2023) 'Effect of oral Calendula officinalis on second-degree burn wound healing', Scars, Burns & Healing, 9, pp. 20595131221134053. doi:10.1177/20595131221134053 Randomized trial
https://doi.org/10.1177/20595131221134053 - Kadowaki, W., Miyata, R., Mizuno, S., Fujinami, M., Sato, Y. and Kumazawa, S (2023) 'Prenylated acetophenones from the roots of Calendula officinalis and their anti-inflammatory activity', Bioscience, Biotechnology, and Biochemistry, 87(7), pp. 683-687. doi:10.1093/bbb/zbad042 Preclinical
https://doi.org/10.1093/bbb/zbad042 - Samra, R.M., Maatooq, G.T. and Zaki, A.A (2022) 'A new antiprotozoal compound from Calendula officinalis', Natural Product Research, 36(22), pp. 5747-5752. doi:10.1080/14786419.2021.2023868 Preclinical
https://doi.org/10.1080/14786419.2021.2023868 - Kaur, J., Sidhu, S., Chopra, K. and Khan, M.U (2016) 'Calendula officinalis ameliorates l-arginine-induced acute necrotizing pancreatitis in rats', Pharmaceutical Biology, 54(12), pp. 2951-2959. doi:10.1080/13880209.2016.1195848 Preclinical
https://doi.org/10.1080/13880209.2016.1195848 - Aro, A.A., Perez, M.O., Vieira, C.P., Esquisatto, M.A.M., Rodrigues, R.A.F., Gomes, L. and Pimentel, E.R (2014) 'Effect of Calendula officinalis cream on achilles tendon healing', Anatomical Record, 298(2), pp. 428-435. doi:10.1002/ar.23057 Preclinical
https://doi.org/10.1002/ar.23057 - Zhang, X., Wang, R., Finiuk, N., Stoika, R., Lin, H., Wang, X. and Jin, M (2023) 'Active compounds from Calendula officinalis flowers act via PI3K and ERK signaling pathways to offer neuroprotective effects against Parkinson's disease', Food Science & Nutrition, 12(1), pp. 450-458. doi:10.1002/fsn3.3792 Preclinical
https://doi.org/10.1002/fsn3.3792 - Kadowaki, W., Miyata, R., Fujinami, M., Sato, Y. and Kumazawa, S (2023) 'Catechol-O-methyltransferase inhibitors from Calendula officinalis leaf', Molecules, 28(3), pp. 1333. doi:10.3390/molecules28031333 Preclinical
https://doi.org/10.3390/molecules28031333 - European Medicines Agency (HMPC) (2018) 'European Union herbal monograph on Calendula officinalis L., flos, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-calendula-officinalis-l-flos-revision-1_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-calendula-officinalis-l-flos-revision-1_en.pdf - Hoffmann, D (2003) 'Medical Herbalism'. Traditional / reference
https://scholar.google.com/scholar?q=Medical%20Herbalism - Nicolaus, C. et al (2017) 'A double-blind, randomized controlled trial to investigate the efficacy and safety of a monograph-based Calendula cream versus a comparator cream', 35(1), pp. 81--89. Randomized trial
https://scholar.google.com/scholar?q=A%20double-blind%2C%20randomized%20controlled%20trial%20to%20investigate%20the%20efficacy%20and%20safety%20of%20a%20monograph-based%20Calendula%20cream%20versus%20a%20comparator%20cream - Preethi, K.C. and Kuttan, R (2009) 'Wound healing activity of flower extract of Calendula officinalis', 20(1), pp. 73--79. doi:10.1515/jbcpp.2009.20.1.73 Preclinical
https://doi.org/10.1515/jbcpp.2009.20.1.73 - Jimenez-Medina, E. and Garcia-Lora, A. and Paco, L. and Algarra, I. and Collado, A. and Garrido, F (2006) 'A new extract of the plant Calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation', BMC Cancer, 6, pp. 119. doi:10.1186/1471-2407-6-119 Preclinical
https://doi.org/10.1186/1471-2407-6-119 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Abenavoli, L., Izzo, A.A., Milic, N., Cicala, C., Santini, A. and Capasso, R (2018) 'Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases', Phytotherapy Research, 32(11), pp. 2202-2213. doi:10.1002/ptr.6171 Meta-analysis / review
https://doi.org/10.1002/ptr.6171 - Bahmani, M., Shirzad, H., Rafieian, S. and Rafieian-Kopaei, M (2015) 'Silybum marianum: Beyond Hepatoprotection', Journal of Evidence-Based Complementary & Alternative Medicine, 20(4), pp. 292-301. doi:10.1177/2156587215571116 Meta-analysis / review
https://doi.org/10.1177/2156587215571116 - Wang, X., Zhang, Z. and Wu, S (2020) 'Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and Applications', Journal of Agricultural and Food Chemistry, 68(42), pp. 11644-11664. doi:10.1021/acs.jafc.0c04791 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.0c04791 - Marmouzi, I., Bouyahya, A., Ezzat, S.M., El Jemli, M. and Kharbach, M (2020) 'The food plant Silybum marianum (L.) Gaertn.: Phytochemistry, Ethnopharmacology and clinical evidence', Journal of Ethnopharmacology, 265, pp. 113303. doi:10.1016/j.jep.2020.113303 Meta-analysis / review
https://doi.org/10.1016/j.jep.2020.113303 - Greenlee, H., Abascal, K., Yarnell, E. and Ladas, E (2007) 'Clinical applications of Silybum marianum in oncology', Integrative Cancer Therapies, 6(2), pp. 158-165. doi:10.1177/1534735407301727 Meta-analysis / review
https://doi.org/10.1177/1534735407301727 - Shaker, E., Mahmoud, H. and Mnaa, S (2009) 'Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage', Food and Chemical Toxicology, 48(3), pp. 803-806. doi:10.1016/j.fct.2009.12.011 Preclinical
https://doi.org/10.1016/j.fct.2009.12.011 - Flora, K., Hahn, M., Rosen, H. and Benner, K (1998) 'Milk thistle (Silybum marianum) for the therapy of liver disease', American Journal of Gastroenterology, 93(2), pp. 139-143. doi:10.1111/j.1572-0241.1998.00139.x Meta-analysis / review
https://doi.org/10.1111/j.1572-0241.1998.00139.x - Csupor, D., Csorba, A. and Hohmann, J (2016) 'Recent advances in the analysis of flavonolignans of Silybum marianum', Journal of Pharmaceutical and Biomedical Analysis, 130, pp. 301-317. doi:10.1016/j.jpba.2016.05.034 Meta-analysis / review
https://doi.org/10.1016/j.jpba.2016.05.034 - Ball, K.R. and Kowdley, K.V (2005) 'A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease', Journal of Clinical Gastroenterology, 39(6), pp. 520-528. doi:10.1097/01.mcg.0000165668.79530.a0 Meta-analysis / review
https://doi.org/10.1097/01.mcg.0000165668.79530.a0 - Tajmohammadi, A., Razavi, B.M. and Hosseinzadeh, H (2018) 'Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review', Phytotherapy Research, 32(10), pp. 1933-1949. doi:10.1002/ptr.6153 Meta-analysis / review
https://doi.org/10.1002/ptr.6153 - Ghahfarrokhi, S.H., Heidari-Soureshjani, S., Sherwin, C.M.T. and Azadegan-Dehkordi, Z (2024) 'Efficacy and Mechanisms of Silybum marianum, Silymarin, and Silibinin on Rheumatoid Arthritis and Osteoarthritis Symptoms: A Systematic Review', Current Rheumatology Reviews, 20(4), pp. 414-425. doi:10.2174/0115733971266397231122080247 Meta-analysis / review
https://doi.org/10.2174/0115733971266397231122080247 - Soleimani, V., Delghandi, P.S., Moallem, S.A. and Karimi, G (2019) 'Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review', Phytotherapy Research. doi:10.1002/ptr.6361 Randomized trial
https://doi.org/10.1002/ptr.6361 - Fallah, M., Davoodvandi, A., Nikmanzar, S., Aghili, S., Mirazimi, S.M.A., Aschner, M., Rashidian, A., Hamblin, M.R., Chamanara, M., Naghsh, N. and Mirzaei, H (2021) 'Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer', Biomedicine & Pharmacotherapy. doi:10.1016/j.biopha.2021.112024 Preclinical
https://doi.org/10.1016/j.biopha.2021.112024 - Voroneanu, L., Nistor, I., Dumea, R., Apetrii, M. and Covic, A (2016) 'Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Journal of Diabetes Research. doi:10.1155/2016/5147468 Meta-analysis / review
https://doi.org/10.1155/2016/5147468 - Zhou, J., Chen, Y., Yu, J., Li, T., Lu, Z., Chen, Y., Zhang, X. and Ye, F (2021) 'The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials', Medicine (Baltimore), 100(12). doi:10.1097/MD.0000000000024884 Meta-analysis / review
https://doi.org/10.1097/MD.0000000000024884 - Fuhr, U., Beckmann-Knopp, S., Jetter, A., Lueck, H. and Mengs, U (2007) 'The effect of silymarin on oral nifedipine pharmacokinetics', Planta Medica, 73(14), pp. 1429-1435. doi:10.1055/s-2007-990256 Randomized trial
https://doi.org/10.1055/s-2007-990256 - Hadi, A., Pourmasoumi, M., Mohammadi, H., Symonds, M. and Miraghajani, M (2018) 'The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials', Complementary Therapies in Medicine, 41, pp. 311-319. doi:10.1016/j.ctim.2018.08.010 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2018.08.010
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.